Alector, Inc. - 8-K Filing
Alector entered a $100M upfront licensing agreement with Genentech for AL050, its GCase ERT program targeting Parkinson's disease (Items: 1.01 Entry Into a Material Definitive Agreement, 2.02 Results of Operations and Financial Condition, 7.01 Regulation FD Disclosure, 8.01 Other Events)
Tickers: $ALEC